Reverb Therapeutics
PrivateLast Round
VC Round
Mar 19, 2026
Total Funding Raised
$24M
Company Overview
Reverb Therapeutics is a biotechnology company that develops bispecific antibodies designed to redirect the body's own cytokines to treat cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Reverb Therapeutics Comparables
Compare Reverb Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Relay Therapeutics | 71% | |
| Ability Biotherapeutics | 69% | |
| Recursion Pharmaceuticals | 68% |
Reverb Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 19, 2026 | ||||
| Seed | Feb 19, 2025 | ||||
| Seed | Nov 15, 2023 |
Key People
Founding team and executive leadership
Reverb Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| InBC Investment Corp. | Seed, VC Round |
| Finchley Healthcare Ventures | Seed |
| Amplitude Ventures | Seed, VC Round |
| Seido Capital | Seed, VC Round |
| KdT Ventures | Seed, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors grew 599% MoM, from 394 to 2.8K.
- Apr 25, 2026
Grew 16% QoQ, from 19 to 22 employees.
Reverb Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Reverb Therapeutics's valuation, stock price, and market status.
Is Reverb Therapeutics a public or private company?
Reverb Therapeutics is a private company.
What is the current stock price of Reverb Therapeutics?
Reverb Therapeutics is a private company, so its shares have no public market price. Caplight tracks Reverb Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Reverb Therapeutics worth (valuation)?
Valuation information for Reverb Therapeutics is not publicly available.
Can I buy Reverb Therapeutics stock?
Reverb Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Reverb Therapeutics's last funding round?
Reverb Therapeutics's most recent funding round was VC Round on March 19, 2026.
Who are the main investors in Reverb Therapeutics?
Key investors in Reverb Therapeutics include Amplitude Ventures.
Will Reverb Therapeutics IPO soon?
No public IPO plans have been announced for Reverb Therapeutics.
How can I track Reverb Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Reverb Therapeutics's shares on secondary markets.